Advanced search
Publication Cover
Acta Obstetricia et Gynecologica Scandinavica Volume 71, 1992 - Issue sup156
Journal homepage
6
Views
5
CrossRef citations to date
0
Altmetric
Original Article

A Comparison Study of Lipid and Androgen Metabolism with Triphasic Oral Contraceptive Formulations Containing Norgestimate or Levonorgestrel

Alain Janaud Hôpital Saint-Louis, Paris
,
Jacques Rouffy Hôpital Saint-Louis, Paris
,
David Upmalis R. W. Johnson Pharmaceutical Research Institute, Raritan, New Jersey
&
Marie-Paule Dain CILAG, France
Pages 33-38 | Published online: 03 Aug 2009

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Giovanni Grandi, Gloria Guariglia & Fabio Facchinetti. (2023) The role of combined oral contraceptives containing norgestimate for acne vulgaris treatment: a review. The European Journal of Contraception & Reproductive Health Care 28:3, pages 184-191.
Read now
Giovanni Grandi, Maria Chiara Del Savio & Fabio Facchinetti. (2021) The paradigm of norgestimate: a third-generation testosterone-derivative progestin with a peripheral anti-androgenic activity and the lowest risk of venous thromboembolism. Expert Review of Clinical Pharmacology 14:2, pages 211-224.
Read now
Françoise Paris, Fangia Rabeolina, Patrick Balaguer, Aleth Bacquet & Charles Sultan. (2007) Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line. Gynecological Endocrinology 23:4, pages 193-197.
Read now
Viveca Odlind, Ian Milsom, Ingemar Persson & Arne Victor. (2002) Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?: A discussion based on recent recommendations from the European agency for evaluation of medicinal products regarding third generation oral contraceptive pills. Acta Obstetricia et Gynecologica Scandinavica 81:6, pages 482-490.
Read now
U. Lachnit-Fixson. (1996) The role of triphasic levonorgestrel in oral contraception: a review of metabolic and hemostatic effects. Gynecological Endocrinology 10:3, pages 207-218.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.